Literature DB >> 16598312

Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome.

C-Y Chen, L-I Lin, J-L Tang, W Tsay, H-H Chang, Y-C Yeh, C-F Huang, R-J Chiou, M Yao, B-S Ko, Y-C Chen, K-H Lin, D-T Lin, H-F Tien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16598312     DOI： 10.1038/sj.leu.2404190

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019.

Authors:  Konnie Hebeda; Ludmila Boudova; Christine Beham-Schmid; Attilio Orazi; Hans-Michael Kvasnicka; Umberto Gianelli; Alexandar Tzankov
Journal:  Ann Hematol       Date:  2020-10-31       Impact factor: 3.673

Review 2.  Therapy-related myelodysplastic syndrome: models and genetics.

Authors:  Timothy Graubert
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-24       Impact factor: 5.742

3.  Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.

Authors:  H A Hou; C C Lin; W C Chou; C Y Liu; C Y Chen; J L Tang; Y J Lai; M H Tseng; C F Huang; Y C Chiang; F Y Lee; Y Y Kuo; M C Lee; M C Liu; C W Liu; L I Lin; M Yao; S Y Huang; B S Ko; S C Hsu; S J Wu; W Tsay; Y C Chen; H F Tien
Journal:  Leukemia       Date:  2013-08-09       Impact factor: 11.528

4.  The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression.

Authors:  Yuan-Yeh Kuo; Hsin-An Hou; Yin-Kai Chen; Li-Yu Li; Po-Hsuen Chen; Mei-Hsuan Tseng; Chi-Fei Huang; Fen-Yu Lee; Ming-Chih Liu; Chia-Wen Liu; Wen-Chien Chou; Chieh-Yu Liu; Jih-Luh Tang; Ming Yao; Hwei-Fang Tien
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

5.  A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN.

Authors:  Wenbin Xiao; Linde A Miles; Robert L Bowman; Vidushi Durani; Helen S Tian; Nicole L DelGaudio; Tanmay Mishra; Menglei Zhu; Yanming Zhang; Sarah E Stump; Martin S Tallman; Ross L Levine; Sheng F Cai
Journal:  Blood Adv       Date:  2020-12-08

6.  Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia.

Authors:  H-A Hou; Y-Y Kuo; C-Y Liu; M C Lee; J-L Tang; C-Y Chen; W-C Chou; C-F Huang; F-Y Lee; M-C Liu; M Yao; H-F Tien
Journal:  Br J Cancer       Date:  2011-11-17       Impact factor: 7.640

7.  Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.

Authors:  Yin-Kai Chen; Hsin-An Hou; Jih-Luh Tang; Jie-Yang Jhuang; Yan-Jun Lai; Ming-Cheng Lee; Yuan-Yeh Kuo; Wen-Chien Chou; Chieh-Yu Liu; Chung-Wu Lin; Shih-Sung Chuang; Chien-Yuan Chen; Mei-Hsuan Tseng; Chi-Fei Huang; Ying-Chieh Chiang; Fen-Yu Lee; Ming-Chih Liu; Chia-Wen Liu; Ming Yao; Shang-Yi Huang; Bor-Sheng Ko; Szu-Chun Hsu; Shang-Ju Wu; Woei Tsay; Yao-Chang Chen; Hwei-Fang Tien
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults.

Authors:  Chieh-Lung Cheng; Chi-Cheng Li; Hsin-An Hou; Wei-Quan Fang; Chin-Hao Chang; Chien-Ting Lin; Jih-Luh Tang; Wen-Chien Chou; Chien-Yuan Chen; Ming Yao; Shang-Yi Huang; Bor-Sheng Ko; Shang-Ju Wu; Woei Tsay; Hwei-Fang Tien
Journal:  BMC Cancer       Date:  2015-05-02       Impact factor: 4.430

9.  Myelodysplastic syndrome transforming to atypical chronic myeloid leukemia shows changes in its mutation allele frequency and acquisition of new mutations.

Authors:  Hakim Nm; Tam W; Philipovskiy A; Tonk V; Orazi A
Journal:  Leuk Res Rep       Date:  2021-05-18

10.  TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.

Authors:  H-A Hou; W-C Chou; Y-Y Kuo; C-Y Liu; L-I Lin; M-H Tseng; Y-C Chiang; M-C Liu; C-W Liu; J-L Tang; M Yao; C-C Li; S-Y Huang; B-S Ko; S-C Hsu; C-Y Chen; C-T Lin; S-J Wu; W Tsay; Y-C Chen; H-F Tien
Journal:  Blood Cancer J       Date:  2015-07-31       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.